Meanwhile, the company is moving ahead with a clinical trial to support the assay's approval in the US.
The method could potentially be useful as a companion diagnostic for targeted drug therapies.
DiaCarta will have the exclusive rights to develop a test for the early detection of colon cancer from stool samples and to commercialize it globally.
The revenue increase is driven by the placement of 22 XT-8 analyzers in the US during the period.
The Geneva-based subsidiary was opened to respond to increasing European demand for the firm's LinkSeq tissue typing test.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.